| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-15-3283-T |
| P8608 | Fatcat ID | release_ecyp2d4zv5abjgsn5xpc7orpzu |
| P932 | PMC publication ID | 5639691 |
| P698 | PubMed publication ID | 28536279 |
| P50 | author | David L Morse | Q90225320 |
| P2093 | author name string | Michael Y Sherman | |
| Leonid A Mirny | |||
| Jacob G Scott | |||
| Jonathan W Wojtkowiak | |||
| Christopher D McFarland | |||
| Julia A Yaglom | |||
| P2860 | cites work | Cancer as an evolutionary and ecological process | Q22122026 |
| Human housekeeping genes, revisited | Q22162505 | ||
| Cancer genome landscapes | Q22242276 | ||
| The effect of deleterious mutations on neutral molecular variation | Q24532876 | ||
| Passenger deletions generate therapeutic vulnerabilities in cancer | Q24598469 | ||
| Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells | Q24657978 | ||
| The human genome browser at UCSC | Q24672361 | ||
| Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
| Deleterious Passengers in Adapting Populations | Q29011147 | ||
| The landscape of cancer genes and mutational processes in breast cancer | Q29614637 | ||
| The causes and consequences of genetic heterogeneity in cancer evolution | Q29615848 | ||
| Genetic basis for clinical response to CTLA-4 blockade in melanoma | Q29620594 | ||
| Human allelic variation: perspective from protein function, structure, and evolution | Q30388182 | ||
| Assessing the evolutionary impact of amino acid mutations in the human genome | Q33339383 | ||
| Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion | Q33739262 | ||
| Mitotic chromosomal instability and cancer: mouse modelling of the human disease. | Q33926467 | ||
| cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate | Q34030518 | ||
| BioMart Central Portal: an open database network for the biological community | Q34217543 | ||
| Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome | Q34381630 | ||
| Tug-of-war between driver and passenger mutations in cancer and other adaptive processes | Q34409055 | ||
| Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer | Q34483582 | ||
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens | Q34788858 | ||
| Antioxidant nutrients and adriamycin toxicity. | Q34904589 | ||
| Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability | Q34984467 | ||
| Paradoxical relationship between chromosomal instability and survival outcome in cancer | Q34988001 | ||
| Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. | Q35453691 | ||
| Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy | Q35840400 | ||
| Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution | Q35909370 | ||
| Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells. | Q36208555 | ||
| Impact of deleterious passenger mutations on cancer progression | Q36637272 | ||
| Molecular and genetic properties of tumors associated with local immune cytolytic activity | Q36869059 | ||
| Model of effectively neutral mutations in which selective constraint is incorporated | Q37337060 | ||
| Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer | Q37660065 | ||
| Pan-cancer patterns of somatic copy number alteration | Q37666205 | ||
| The aneuploidy paradox: costs and benefits of an incorrect karyotype | Q37923163 | ||
| Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics | Q37970854 | ||
| 'Latent drivers' expand the cancer mutational landscape | Q38347554 | ||
| The mini-driver model of polygenic cancer evolution | Q38604664 | ||
| Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. | Q40139573 | ||
| High order chromatin architecture shapes the landscape of chromosomal alterations in cancer | Q40719732 | ||
| Aneuploidy acts both oncogenically and as a tumor suppressor | Q44738012 | ||
| A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. | Q51584233 | ||
| Transitions to asexuality result in excess amino acid substitutions. | Q51950373 | ||
| Defining stem cell dynamics in models of intestinal tumor initiation. | Q53130842 | ||
| The mutation rate and cancer | Q74481910 | ||
| Adaptive evolution of asexual populations under Muller's ratchet | Q80514758 | ||
| MULLER'S RATCHET AND MUTATIONAL MELTDOWNS | Q88206287 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-05-23 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | The Damaging Effect of Passenger Mutations on Cancer Progression |
| Q90893993 | Approaches to treat immune hot, altered and cold tumours with combination immunotherapies |
| Q89556013 | Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate |
| Q64077856 | Burden of unique and low prevalence somatic mutations correlates with cancer survival |
| Q52361028 | Collective effects of common SNPs and risk prediction in lung cancer. |
| Q56673276 | Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter |
| Q91618178 | Evaluation of colorectal cancer subtypes and cell lines using deep learning |
| Q98733541 | Evidence for hypoxia increasing the tempo of evolution in glioblastoma |
| Q91795790 | Functional Characterization of Colon Cancer-Associated Mutations in ADAM17: Modifications in the Pro-Domain Interfere with Trafficking and Maturation |
| Q94948533 | Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden |
| Q89590839 | Impact of accumulated alterations in driver and passenger genes on response to radiation therapy |
| Q96109608 | Integrated Multi-omics Data Analyses for Exploring the Co-occurring and Mutually Exclusive Gene Alteration Events in Colorectal Cancer |
| Q57135123 | MUC16 mutations improve patients' prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment |
| Q61450767 | Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia |
| Q103806007 | Mutation-selection balance and compensatory mechanisms in tumour evolution |
| Q92172404 | POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction |
| Q89013777 | Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution |
| Q91891714 | Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis |
| Q92636849 | Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants |
| Q61800092 | Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities |
| Q89746470 | The paradox of cancer genes in non-malignant conditions: implications for precision medicine |
| Q90440514 | Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence |
| Q45395608 | p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry |
Search more.